Lyme Disease
An infectious disease caused by a spirochete, BORRELIA BURGDORFERI, which is transmitted chiefly by Ixodes dammini (see IXODES) and pacificus ticks in the United States and Ixodes ricinis (see IXODES) in Europe. It is a disease with early and late cutaneous manifestations plus involvement of the nervous system, heart, eye, and joints in variable combinations. The disease was formerly known as Lyme arthritis and first discovered at Old Lyme, Connecticut.
Subtype terms (3)
More specific conditions that are subtypes of Lyme Disease in the MeSH hierarchy.
- Erythema Chronicum Migrans
4 drugs approved
- Lyme Neuroborreliosis
5 drugs (3 approved, 2 experimental)
- Post-Lyme Disease Syndrome
4 drugs (2 approved, 2 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (5)
Phase 3 trials (3)
Phase 2 trials (5)
Phase 1 trials (2)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (7)